The present invention is directed to compositions and methods related to carbohydrate-based backbone CD206-targeting molecules. Described herein are compositions for diagnosing and treating disorders, for example but without limitation, inflammasome-mediated disorders. The compositions described herein can act as carrier molecules for delivering diagnostic and therapeutic agents.